Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Onset of a pandemic: characterizing the initial phase of the swine flu (H1N1) epidemic in Israel

Authors: Uri Roll, Rami Yaari, Guy Katriel, Oren Barnea, Lewi Stone, Ella Mendelson, Michal Mandelboim, Amit Huppert

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

The swine influenza H1N1 first identified in Mexico, spread rapidly across the globe and is considered the fastest moving pandemic in history. The early phase of an outbreak, in which data is relatively scarce, presents scientific challenges on key issues such as: scale, severity and immunity which are fundamental for establishing sound and rapid policy schemes. Our analysis of an Israeli dataset aims at understanding the spatio-temporal dynamics of H1N1 in its initial phase.

Methods

We constructed and analyzed a unique dataset from Israel on all confirmed cases (between April 26 to July 7, 2009), representing most swine flu cases in this period. We estimated and characterized fundamental epidemiological features of the pandemic in Israel (e.g. effective reproductive number, age-class distribution, at-risk social groups, infections between sexes, and spatial dynamics). Contact data collected during this stage was used to estimate the generation time distribution of the pandemic.

Results

We found a low effective reproductive number (R e = 1.06), an age-class distribution of infected individuals (skewed towards ages 18-25), at-risk social groups (soldiers and ultra Orthodox Jews), and significant differences in infections between sexes (skewed towards males). In terms of spatial dynamics, the pandemic spread from the central coastal plain of Israel to other regions, with higher infection rates in more densely populated sub-districts with higher income households.

Conclusions

Analysis of high quality data holds much promise in reducing uncertainty regarding fundamental aspects of the initial phase of an outbreak (e.g. the effective reproductive number Re, age-class distribution, at-risk social groups). The formulation for determining the effective reproductive number R e used here has many advantages for studying the initial phase of the outbreak since it neither assumes exponential growth of infectives and is independent of the reporting rate. The finding of a low R e (close to unity threshold), combined with identification of social groups with high transmission rates would have enabled the containment of swine flu during the summer in Israel. Our unique use of contact data provided new insights into the differential dynamics of influenza in different ages and sexes, and should be promoted in future epidemiological studies. Thus our work highlights the importance of conducting a comprehensive study of the initial stage of a pandemic in real time.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM: Managing and Reducing Uncertainty in an Emerging Influenza Pandemic. New England Journal of Medicine. 2009, 361 (2): 112-115. 10.1056/NEJMp0904380.CrossRefPubMedPubMedCentral Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM: Managing and Reducing Uncertainty in an Emerging Influenza Pandemic. New England Journal of Medicine. 2009, 361 (2): 112-115. 10.1056/NEJMp0904380.CrossRefPubMedPubMedCentral
3.
go back to reference Flahault A, Vergu E, Boelle PY: Potential for a global dynamic of Influenza A (H1N1). Bmc Infectious Diseases. 2009, 9: 10.1186/1471-2334-9-129. Flahault A, Vergu E, Boelle PY: Potential for a global dynamic of Influenza A (H1N1). Bmc Infectious Diseases. 2009, 9: 10.1186/1471-2334-9-129.
4.
go back to reference Morens DM, Taubenberger JK: Understanding Influenza Backward. Jama-Journal of the American Medical Association. 2009, 302 (6): 679-680. 10.1001/jama.2009.1127.CrossRef Morens DM, Taubenberger JK: Understanding Influenza Backward. Jama-Journal of the American Medical Association. 2009, 302 (6): 679-680. 10.1001/jama.2009.1127.CrossRef
5.
go back to reference Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu XY, Bridges CB, Uyeki TM: Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. New England Journal of Medicine. 2009, 360 (25): 2605-2615. 10.1056/NEJMoa0903810.CrossRefPubMed Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu XY, Bridges CB, Uyeki TM: Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. New England Journal of Medicine. 2009, 360 (25): 2605-2615. 10.1056/NEJMoa0903810.CrossRefPubMed
6.
go back to reference Ahmed R, Oldstone MBA, Palese P: Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nature Immunology. 2007, 8 (11): 1188-1193. 10.1038/ni1530.CrossRefPubMed Ahmed R, Oldstone MBA, Palese P: Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nature Immunology. 2007, 8 (11): 1188-1193. 10.1038/ni1530.CrossRefPubMed
7.
go back to reference Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K: Pandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution. The Journal of Infectious Diseases. 1998, 178 (1): 53-60.CrossRefPubMed Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K: Pandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution. The Journal of Infectious Diseases. 1998, 178 (1): 53-60.CrossRefPubMed
9.
go back to reference Mendelson E, Mandelboim M, Grossman Z, Ram D, Hindiyeh M: Laboratory diagnosis of influenza H1N1 2009 at the Central Virology Laboratory in Israel during the first 12 weeks of the pandemic. Harefuah. 2009, 148: 677-671.PubMed Mendelson E, Mandelboim M, Grossman Z, Ram D, Hindiyeh M: Laboratory diagnosis of influenza H1N1 2009 at the Central Virology Laboratory in Israel during the first 12 weeks of the pandemic. Harefuah. 2009, 148: 677-671.PubMed
11.
go back to reference Kermack WO, McKendrick AG: A Contribution to the Mathematical Theory of Epidemics. Proceedings of the Royal Society of London Series A. 1927, 115 (772): 700-721. 10.1098/rspa.1927.0118.CrossRef Kermack WO, McKendrick AG: A Contribution to the Mathematical Theory of Epidemics. Proceedings of the Royal Society of London Series A. 1927, 115 (772): 700-721. 10.1098/rspa.1927.0118.CrossRef
12.
go back to reference White LF, Pagano M: A likelihood-based method for real-time estimation of the serial interval and reproductive number of an epidemic. Statistics in Medicine. 2008, 27 (16): 2999-3016. 10.1002/sim.3136.CrossRefPubMedPubMedCentral White LF, Pagano M: A likelihood-based method for real-time estimation of the serial interval and reproductive number of an epidemic. Statistics in Medicine. 2008, 27 (16): 2999-3016. 10.1002/sim.3136.CrossRefPubMedPubMedCentral
13.
go back to reference Katriel G, Yaari R, Huppert A, Roll U, Stone L: Modelling the initial phase of an epidemic using incidence and infection network data: 2009 H1N1 pandemic in Israel as a case study. Journal of the Royal Society Interface. 2011, 8 (59): 856-867. 10.1098/rsif.2010.0515.CrossRefPubMedCentral Katriel G, Yaari R, Huppert A, Roll U, Stone L: Modelling the initial phase of an epidemic using incidence and infection network data: 2009 H1N1 pandemic in Israel as a case study. Journal of the Royal Society Interface. 2011, 8 (59): 856-867. 10.1098/rsif.2010.0515.CrossRefPubMedCentral
14.
go back to reference Zar JH: Biostatistical analysis. 1999, Upper Saddle River, N.J.: Prentice Hall, 4 Zar JH: Biostatistical analysis. 1999, Upper Saddle River, N.J.: Prentice Hall, 4
16.
go back to reference Anderson DR: Model based inference in the life sciences, a primer on evidence. 2008, New York, NY: SpringerCrossRef Anderson DR: Model based inference in the life sciences, a primer on evidence. 2008, New York, NY: SpringerCrossRef
17.
go back to reference Reichert T, Chowell G, Nishiura H, Christensen R, McCullers J: Does glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?. Bmc Infectious Diseases. 2010, 10 (1): 5-10.1186/1471-2334-10-5.CrossRefPubMedPubMedCentral Reichert T, Chowell G, Nishiura H, Christensen R, McCullers J: Does glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?. Bmc Infectious Diseases. 2010, 10 (1): 5-10.1186/1471-2334-10-5.CrossRefPubMedPubMedCentral
18.
go back to reference Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ: Time lines of infection and disease in human influenza: A review of volunteer challenge studies. American Journal of Epidemiology. 2008, 167 (7): 775-785. 10.1093/aje/kwm375.CrossRefPubMed Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ: Time lines of infection and disease in human influenza: A review of volunteer challenge studies. American Journal of Epidemiology. 2008, 167 (7): 775-785. 10.1093/aje/kwm375.CrossRefPubMed
19.
go back to reference Ammon A, Ciancio B, Coulombier D, Devaux I, Kreidl P, Plata F, Salminen M, Zucs P, H1N EWGIA: Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries. Eurosurveillance. 2009, 14 (23): Ammon A, Ciancio B, Coulombier D, Devaux I, Kreidl P, Plata F, Salminen M, Zucs P, H1N EWGIA: Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries. Eurosurveillance. 2009, 14 (23):
20.
go back to reference Belgian working group on influenza A(H1N1)v: Influenza A(H1N1)v virus infections in Belgium, May-June 2009. Eurosurveillance. 2009, 14 (28): pii =19270 Belgian working group on influenza A(H1N1)v: Influenza A(H1N1)v virus infections in Belgium, May-June 2009. Eurosurveillance. 2009, 14 (28): pii =19270
22.
go back to reference Influenza A(H1N1)v investigation teams: Modified surveillance of influenza A(H1N1)v virus infections in France. Eurosurveillance. 2009, 14 (29): pii = 19276- Influenza A(H1N1)v investigation teams: Modified surveillance of influenza A(H1N1)v virus infections in France. Eurosurveillance. 2009, 14 (29): pii = 19276-
23.
go back to reference Rizzo C, Declich S, Bella A, Caporali MG, Lana S, Pompa MG, Vellucci L, Salmaso S: Enhanced epidemiological surveillance of influenza A(H1N1)v in Italy. Eurosurveillance. 2009, 14 (27): 6-9. Rizzo C, Declich S, Bella A, Caporali MG, Lana S, Pompa MG, Vellucci L, Salmaso S: Enhanced epidemiological surveillance of influenza A(H1N1)v in Italy. Eurosurveillance. 2009, 14 (27): 6-9.
24.
go back to reference Lytras T, Theocharopoulos G, Tsiodras S, Mentis A, Panagiotopoulos T, Bonovas S, the inluenza surveillance report group: Enhanced surveillance of influenza A(H1N1)v in Greece during the containment phase. Eurosurveillance. 2009, 14 (29): pii = 19275- Lytras T, Theocharopoulos G, Tsiodras S, Mentis A, Panagiotopoulos T, Bonovas S, the inluenza surveillance report group: Enhanced surveillance of influenza A(H1N1)v in Greece during the containment phase. Eurosurveillance. 2009, 14 (29): pii = 19275-
25.
go back to reference INSS: Middle East Military Balance - chapter Israel. Edited by: Studies TIfNS. 2009 INSS: Middle East Military Balance - chapter Israel. Edited by: Studies TIfNS. 2009
26.
go back to reference Levin H: Ultra orthodox employment. 2009, National economic council Ipmso Levin H: Ultra orthodox employment. 2009, National economic council Ipmso
27.
go back to reference Miller MA, Viboud C, Balinska M, Simonsen L: The Signature Features of Influenza Pandemics - Implications for Policy. New England Journal of Medicine. 2009, 360 (25): 2595-2598. 10.1056/NEJMp0903906.CrossRefPubMed Miller MA, Viboud C, Balinska M, Simonsen L: The Signature Features of Influenza Pandemics - Implications for Policy. New England Journal of Medicine. 2009, 360 (25): 2595-2598. 10.1056/NEJMp0903906.CrossRefPubMed
28.
go back to reference Lau LLH, Cowling BJ, Fang VJ, Chan KH, Lau EHY, Lipsitch M, Cheng CKY, Houck PM, Uyeki TM, Peiris JSM, et al: Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus Infections. Journal of Infectious Diseases. 2010, 201 (10): 1509-1516. 10.1086/652241.CrossRefPubMedPubMedCentral Lau LLH, Cowling BJ, Fang VJ, Chan KH, Lau EHY, Lipsitch M, Cheng CKY, Houck PM, Uyeki TM, Peiris JSM, et al: Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus Infections. Journal of Infectious Diseases. 2010, 201 (10): 1509-1516. 10.1086/652241.CrossRefPubMedPubMedCentral
29.
go back to reference Papenburg J, Baz M, Hamelin ME, Rheaume C, Carbonneau J, Ouakki M, Rouleau I, Hardy I, Skowronski D, Roger M, et al: Household Transmission of the 2009 Pandemic A/H1N1 Influenza Virus: Elevated Laboratory-Confirmed Secondary Attack Rates and Evidence of Asymptomatic Infections. Clin Infect Dis. 2010, 51 (9): 1033-1041. 10.1086/656582.CrossRefPubMed Papenburg J, Baz M, Hamelin ME, Rheaume C, Carbonneau J, Ouakki M, Rouleau I, Hardy I, Skowronski D, Roger M, et al: Household Transmission of the 2009 Pandemic A/H1N1 Influenza Virus: Elevated Laboratory-Confirmed Secondary Attack Rates and Evidence of Asymptomatic Infections. Clin Infect Dis. 2010, 51 (9): 1033-1041. 10.1086/656582.CrossRefPubMed
30.
go back to reference Tandale B, Pawar S, Gurav Y, Chadha M, Koratkar S, Shelke V, Mishra A: Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. Bmc Infectious Diseases. 2010, 10 (1): 255-10.1186/1471-2334-10-255.CrossRefPubMedPubMedCentral Tandale B, Pawar S, Gurav Y, Chadha M, Koratkar S, Shelke V, Mishra A: Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. Bmc Infectious Diseases. 2010, 10 (1): 255-10.1186/1471-2334-10-255.CrossRefPubMedPubMedCentral
31.
go back to reference Lee VJ, Yap J, Tay JK, Barr I, Gao QH, Ho HJ, Tan BH, Kelly PM, Tambyah PA, Kelso A, et al: Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009. Bmc Infectious Diseases. 2010, 10: 6-10.1186/1471-2334-10-6.CrossRef Lee VJ, Yap J, Tay JK, Barr I, Gao QH, Ho HJ, Tan BH, Kelly PM, Tambyah PA, Kelso A, et al: Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009. Bmc Infectious Diseases. 2010, 10: 6-10.1186/1471-2334-10-6.CrossRef
32.
go back to reference Hsu SB, Hsieh YH: On the Role of Asymptomatic Infection in Transmission Dynamics of Infectious Diseases. Bulletin of Mathematical Biology. 2008, 70: 134-155. 10.1007/s11538-007-9245-6.CrossRefPubMed Hsu SB, Hsieh YH: On the Role of Asymptomatic Infection in Transmission Dynamics of Infectious Diseases. Bulletin of Mathematical Biology. 2008, 70: 134-155. 10.1007/s11538-007-9245-6.CrossRefPubMed
33.
go back to reference Patrozou E, Mermel LA: Does influenza transmission occur from asymptomatic infection or prior to symptom onset?. Public Health Reports. 2009, 124 (2): 193-196.PubMedPubMedCentral Patrozou E, Mermel LA: Does influenza transmission occur from asymptomatic infection or prior to symptom onset?. Public Health Reports. 2009, 124 (2): 193-196.PubMedPubMedCentral
34.
go back to reference Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, et al: Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings. Science. 2009, 324 (5934): 1557-1561. 10.1126/science.1176062.CrossRefPubMedPubMedCentral Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, et al: Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings. Science. 2009, 324 (5934): 1557-1561. 10.1126/science.1176062.CrossRefPubMedPubMedCentral
35.
go back to reference Tuite AR, Greer AL, Whelan M, Winter AL, Lee B, Yan P, Wu J, Moghadas S, Buckeridge D, Pourbohloul B, et al: Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ. 2009, cmaj.091807- Tuite AR, Greer AL, Whelan M, Winter AL, Lee B, Yan P, Wu J, Moghadas S, Buckeridge D, Pourbohloul B, et al: Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ. 2009, cmaj.091807-
36.
go back to reference Cruz-Pacheco G, Duran L, Esteva L, Minzoni AA, Lopez-Cervantes M, Panayotaros P, Ortega AA, Ruiz IV: Modeling of the influenza A(H1N1)v outbreak in Mexico city, April-May 2009, with control sanitary measure. Eurosurveillance. 2009, 14 (26): Cruz-Pacheco G, Duran L, Esteva L, Minzoni AA, Lopez-Cervantes M, Panayotaros P, Ortega AA, Ruiz IV: Modeling of the influenza A(H1N1)v outbreak in Mexico city, April-May 2009, with control sanitary measure. Eurosurveillance. 2009, 14 (26):
37.
go back to reference McBryde ES, Bergeri I, van Gemert C, Rotty J, Headley EJ, Simpson K, Lester RA, Hellard M, Fielding JE: Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian state 16 May - 3 June 2009. Eurosurveillance. 2009, 14 (42): pii = 19363- McBryde ES, Bergeri I, van Gemert C, Rotty J, Headley EJ, Simpson K, Lester RA, Hellard M, Fielding JE: Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian state 16 May - 3 June 2009. Eurosurveillance. 2009, 14 (42): pii = 19363-
38.
go back to reference Nishiura H, Castillo-Chavez C, Safan M, Chowell G: Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Eurosurveillance. 2009, 14 (22): 4- Nishiura H, Castillo-Chavez C, Safan M, Chowell G: Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Eurosurveillance. 2009, 14 (22): 4-
39.
go back to reference Nishiura H, Wilson N, Baker MG: Estimating the reproduction number of the novel influenza A virus (H1N1) in a Southern Hemisphere setting: preliminary estimate in New Zealand. The New Zealand Medical Journal. 2009, 122 (1299): 73-77.PubMed Nishiura H, Wilson N, Baker MG: Estimating the reproduction number of the novel influenza A virus (H1N1) in a Southern Hemisphere setting: preliminary estimate in New Zealand. The New Zealand Medical Journal. 2009, 122 (1299): 73-77.PubMed
40.
go back to reference White LF, Wallinga J, Finelli L, Reed C, Riley S, Lipsitch M, Pagano M: Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza and Other Respiratory Viruses. 2009, 3 (6): 267-276. 10.1111/j.1750-2659.2009.00106.x.CrossRefPubMedPubMedCentral White LF, Wallinga J, Finelli L, Reed C, Riley S, Lipsitch M, Pagano M: Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza and Other Respiratory Viruses. 2009, 3 (6): 267-276. 10.1111/j.1750-2659.2009.00106.x.CrossRefPubMedPubMedCentral
41.
go back to reference Chowell G, Nishiura H, Bettencourt LMA: Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. Journal of the Royal Society Interface. 2007, 4 (12): 155-166. 10.1098/rsif.2006.0161.CrossRef Chowell G, Nishiura H, Bettencourt LMA: Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. Journal of the Royal Society Interface. 2007, 4 (12): 155-166. 10.1098/rsif.2006.0161.CrossRef
42.
go back to reference Balcan D, Hu H, Goncalves B, Bajardi P, Poletto C, Ramasco JJ, Paolotti D, Perra N, Tizzoni M, Van den Broeck W, et al: Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility. Bmc Medicine. 2009, 7: 10.1186/1741-7015-7-45. Balcan D, Hu H, Goncalves B, Bajardi P, Poletto C, Ramasco JJ, Paolotti D, Perra N, Tizzoni M, Van den Broeck W, et al: Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility. Bmc Medicine. 2009, 7: 10.1186/1741-7015-7-45.
43.
go back to reference Hahne S, Donker T, Meijer A, Timen A, van Steenbergen J, Osterhaus A, van der Sande M, Koopmans M, Wallinga J, Coutinho R, et al: Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. Eurosurveillance. 2009, 14 (27): 2-5. Hahne S, Donker T, Meijer A, Timen A, van Steenbergen J, Osterhaus A, van der Sande M, Koopmans M, Wallinga J, Coutinho R, et al: Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. Eurosurveillance. 2009, 14 (27): 2-5.
44.
go back to reference Charland KML, Buckeridge DL, Sturtevant JL, Melton F, Reis BY, Mandl KD, Brownstein JS: Effect of environmental factors on the spatio-temporal patterns of influenza spread. Epidemiology and Infection. 2009, 137 (10): 1377-1387. 10.1017/S0950268809002283.CrossRefPubMed Charland KML, Buckeridge DL, Sturtevant JL, Melton F, Reis BY, Mandl KD, Brownstein JS: Effect of environmental factors on the spatio-temporal patterns of influenza spread. Epidemiology and Infection. 2009, 137 (10): 1377-1387. 10.1017/S0950268809002283.CrossRefPubMed
45.
go back to reference McCaw JM, McVernon J, McBryde ES, Mathews JD: Influenza: Accounting for Prior Immunity. Science. 2009, 325 (5944): 1071-1071. 10.1126/science.325_1071a.CrossRefPubMed McCaw JM, McVernon J, McBryde ES, Mathews JD: Influenza: Accounting for Prior Immunity. Science. 2009, 325 (5944): 1071-1071. 10.1126/science.325_1071a.CrossRefPubMed
46.
go back to reference Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N, Vita R, Ponomarenko J, Scheuermann RH, Sette A, et al: Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proceedings of the National Academy of Sciences of the United States of America. 2009, 106 (48): 20365-20370. 10.1073/pnas.0911580106.CrossRefPubMedPubMedCentral Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N, Vita R, Ponomarenko J, Scheuermann RH, Sette A, et al: Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proceedings of the National Academy of Sciences of the United States of America. 2009, 106 (48): 20365-20370. 10.1073/pnas.0911580106.CrossRefPubMedPubMedCentral
47.
go back to reference Fraser C, Riley S, Anderson RM, Ferguson NM: Factors that make an infectious disease outbreak controllable. Proceedings of the National Academy of Sciences of the United States of America. 2004, 101 (16): 6146-6151. 10.1073/pnas.0307506101.CrossRefPubMedPubMedCentral Fraser C, Riley S, Anderson RM, Ferguson NM: Factors that make an infectious disease outbreak controllable. Proceedings of the National Academy of Sciences of the United States of America. 2004, 101 (16): 6146-6151. 10.1073/pnas.0307506101.CrossRefPubMedPubMedCentral
48.
go back to reference Barrett JP, Rosen iM, Harris JR, Stout LR, Murphy RA, Martin DP: Respiratory illnesses at the 2009 U.S. Army ROTC advanced camp. Military Medicine. 2010, 175 (12): 990-994.CrossRefPubMed Barrett JP, Rosen iM, Harris JR, Stout LR, Murphy RA, Martin DP: Respiratory illnesses at the 2009 U.S. Army ROTC advanced camp. Military Medicine. 2010, 175 (12): 990-994.CrossRefPubMed
49.
go back to reference Green MS: The male predominance in the incidence of infectious-diseases in children - a postulated explanation for disparities in the literature. Int J Epidemiol. 1992, 21 (2): 381-386. 10.1093/ije/21.2.381.CrossRefPubMed Green MS: The male predominance in the incidence of infectious-diseases in children - a postulated explanation for disparities in the literature. Int J Epidemiol. 1992, 21 (2): 381-386. 10.1093/ije/21.2.381.CrossRefPubMed
50.
go back to reference Carlsson-Kanyama A, Linden AL: Travel patterns and environmental effects now and in the future: implications of differences in energy consumption among socio-economic groups. Ecological Economics. 1999, 30 (3): 405-417. 10.1016/S0921-8009(99)00006-3.CrossRef Carlsson-Kanyama A, Linden AL: Travel patterns and environmental effects now and in the future: implications of differences in energy consumption among socio-economic groups. Ecological Economics. 1999, 30 (3): 405-417. 10.1016/S0921-8009(99)00006-3.CrossRef
51.
go back to reference Strachan NJC, Watson RO, Novik V, Hofreuter D, Ogden ID, Galan JE: Sexual dimorphism in campylobacteriosis. Epidemiology and Infection. 2008, 136 (11): 1492-1495. 10.1017/S0950268807009934.CrossRefPubMed Strachan NJC, Watson RO, Novik V, Hofreuter D, Ogden ID, Galan JE: Sexual dimorphism in campylobacteriosis. Epidemiology and Infection. 2008, 136 (11): 1492-1495. 10.1017/S0950268807009934.CrossRefPubMed
52.
go back to reference Eisenberg JNS, Aiello AE, Spicknall IH, Monto AS, Reingold A: Protecting the Herd from H1N1. Science. 2009, 326 (5955): 934-934. 10.1126/science.326.5955.934-a.CrossRefPubMed Eisenberg JNS, Aiello AE, Spicknall IH, Monto AS, Reingold A: Protecting the Herd from H1N1. Science. 2009, 326 (5955): 934-934. 10.1126/science.326.5955.934-a.CrossRefPubMed
53.
go back to reference Mallet WJ: Long-distance travel by low-income households. Transportation Research Circular. 2001, E-C026: 169-177. Mallet WJ: Long-distance travel by low-income households. Transportation Research Circular. 2001, E-C026: 169-177.
54.
go back to reference Israel Central Bureau of Statistics: Israeli annual statistical report. 2009 Israel Central Bureau of Statistics: Israeli annual statistical report. 2009
55.
go back to reference CDC: Director's Update Brief novel 2009-H1N1. 2009 CDC: Director's Update Brief novel 2009-H1N1. 2009
Metadata
Title
Onset of a pandemic: characterizing the initial phase of the swine flu (H1N1) epidemic in Israel
Authors
Uri Roll
Rami Yaari
Guy Katriel
Oren Barnea
Lewi Stone
Ella Mendelson
Michal Mandelboim
Amit Huppert
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-92

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.